health
(Boston, MA) — Boston University researchers say a new blood test could potentially diagnose chronic traumatic encephalopathy, or CTE, in living patients. The degenerative brain disease, commonly linked to repeated head injuries, can currently only be definitively diagnosed after death. Researchers examined...
Read More
Pennsylvania confirms eighth measles-related death amid US outbreak
By Siddhi Mahatole
Nov 18 (Reuters) – The Pennsylvania Department of Health on Wednesday confirmed the state’s eighth death associated with measles this year, the latest fatality linked to an outbreak of the highly contagious viral disease.
The agency said the...
Read More
Powerful Storms To Slam West Coast
(Undated) — The West Coast is bracing for some strong storms this week. The main threats will be heavy rain, strong winds, and massive waves. The coastlines of Washington, Oregon and California are expected to be the highest risk areas. Other states like Arizona and Nevada...
Read More
health Headlines
- Bausch + Lomb’s eye-drop drug fails to reduce pain after laser surgery in trial
- Celldex ends eczema drug development after mid-stage trial failure
Procter & Gamble targets up to $10 billion in productivity savings as costs stack up
FDA sets up council for post-market review of vaccines, gene therapies
Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports- HK-listed Guangzhou Innogen signs over $1 billion licensing deal for diabetes drug
France on high alert for bird flu as seasonal wave spreads
AbbVie expands bispecific cancer med push with up to $2.5 billion deal with Germany’s Disco
Novartis trims medium-term growth target, shares fall- Pharmacy chain Big Caring ends 0.9% higher after $155 million Malaysia IPO
Weight-loss drugs’ hit to UK grocery spending tops £1 billion, Worldpanel says
US FDA approves Regeneron’s drug for generalized myasthenia gravis (November 18)
Sanofi’s pill becomes first US-approved drug for rare neurological disorder- EU too slow tackling health risks from ‘forever chemicals’, auditors say
Bristol’s schizophrenia drug helps Alzheimer’s-related psychosis symptoms, preliminary data shows- Cal-Maine to cull 1.8 million birds, halt production at Florida facility after bird flu detected
Pfizer licenses CAR-T therapies from China’s Starna in up to $2.6 billion deal
New blood test measures Alzheimer’s progression
UnitedHealthcare to expand program paying pharmacists for medical services- British cancer drug developer Ellipses Pharma considers London listing (November 18)
- IPO-bound Aragen plans to spend 1.5 billion rupees over 2 years for expansion, MD says
Trump withdraws Heidi Overton’s nomination to lead FDA
Haiti’s gang violence blocks aid as child malnutrition worsens
Biogen’s anti-tau Alzheimer’s drug benefits increase at 2 years
Merck stops trials of blood cancer drug after review of risks
US FDA approves GSK’s second lung cancer drug from historic Nuvalent deal
US loses measles elimination status after nearly three decades; Mexico, Bolivia also lose designation
Gilead signs generic licensing deals for experimental Ebola drug
US FDA proposes to withdraw approval for Salerno’s cholesterol medication- AI drug developer Isomorphic raises $5 billion in Series C round
- Sellas vaccine extends survival in blood cancer trial, shares surge
Congo’s Ebola outbreak is spreading and killing at a record pace- Exclusive-Authorities raid factory making illegal Chinese vapes in the US
Barrick furloughing some Congo mine personnel over Ebola concerns- Getting Off GLP-1 Drugs May Be Problematic
Trial lawyer Lanier joins investor lawsuit over J&J’s talc disclosures- Australia’s Mayne Pharma jumps to 1-year high on $408 million Gedeon Richter takeover
L’Oreal US settles hair relaxer cancer cases during first trial- Incyte says EU approves oral treatment for chronic skin disease
Lilly signs cancer research deal with Stipple Bio worth up to $5.9 billion- Rhythm drug shows sustained weight reduction in patients with brain damage-related obesity
US FDA approves Roche’s oral treatment for advanced breast cancer- Venture firm Flagship bets £100 million to build AI-driven drug companies in Britain
Pennsylvania measles cases rise to 1,561, state health department says
US must intensify vaccination effort to regain measles-free status lost after 26 years
Teva settles US states’ drug price-fixing case
US FDA approves at-home use of BioXcel’s agitation drug- CG Oncology’s immunotherapy reduces risk of tumor recurrence in bladder cancer trial
J&J to buy eye disease biotech Ollin Biosciences for up to $3.3 billion
Lilly to buy Calytrix for up to $1.5 billion in rare blood cancer bet
